The U.S. government on Friday announced pilot programs to start in 2026 and 2027 that are aimed at reducing out-of-pocket drug costs under the Medicare healthcare program for older and disabled Americans to prices on par with economically comparable countries. The Centers for Medicare and Medicaid Services said the programs, titled Guarding U.S. Medicare Against Rising Drug Costs (GUARD) and Global Benchmark for Efficient Drug Pricing (GLOBE), would assess a rebate for certain drugs payable under Medicare part D and Part B, respectively, if they exceed the prices paid in other similar countries.
Read the full article: US Health Agency Announces Two Medicare Pilot Programs on Drug Pricing //
Source: https://www.reuters.com/legal/litigation/us-health-agency-announces-two-medicare-pilot-programs-drug-pricing-2025-12-19/